EnsoData helps Aeroflow double patient PAP adherence rates
Aeroflow Sleep’s mission is to help patients sleep well and live better by providing resources, services, and the PAP equipment and supplies needed to easily navigate the sleep apnea journey. In the following short video clips, Joey Sasvari, Director of Sleep at Aeroflow Health, highlights common challenges in the traditional PAP coaching process, how AI is supporting their sleep coaches, and how adding AI is improving patient PAP adherence results.
One of Aeroflow’s primary challenges in the PAP therapy pathway is ensuring that patients achieve 90-day compliance, and providing clinical support to help patients reach this goal is a top priority for their sleep coaching team.
To address this challenge, Aeroflow partnered with EnsoData to integrate EnsoTherapy into their sleep coaching workflow. EnsoTherapy is an AI solution that predicts 90-day therapy adherence within days of sleep apnea patients starting treatment. For Aeroflow, this meant providing their sleep coaches with valuable data to prioritize contacting the patients who would benefit most from intervention.
Adding EnsoTherapy helped Aeroflow expedite the patient experience with more personalized care. EnsoTherapy helps identify which patient needs attention the most and when they need that intervention, improving overall treatment success rates among Aeroflow patients.
As a result of adding EnsoTherapy, the Aeroflow team has seen some fast, powerful results. Aeroflow’s sleep coaches are able to address patient needs faster and more efficiently, and that has resulted in patient usage rates doubling in the first 60 days of EnsoTherapy use.
To learn more about EnsoTherapy, schedule a conversation with a member of our team.
